Share of the population living with HIV receiving antiretroviral therapy in Somalia, Fed. Rep.

Somalia, Fed. Rep.: Share of the population living with HIV receiving antiretroviral therapy was 61.9% in 2024. β—† Volatile

Latest (2024)
61.9%
Change on year
up 9.7%
World rank
104th
of 149 countries
All-time high
61.9%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Somalia, Fed. Rep., 1990–2024

02040601990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0 %2000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 0.367 %2006: 0.897 %2007: 1.8 %2008: 3.6 %2009: 5.2 %2010: 8.3 %2011: 11.3 %2012: 14.9 %2013: 18.4 %2014: 20.5 %2015: 25.4 %2016: 29.5 %2017: 33.8 %2018: 37 %2019: 40.2 %2020: 43.3 %2021: 46.1 %2022: 49.5 %2023: 56.4 %2024: 61.9 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

In 2024, share of the population living with hiv receiving antiretroviral therapy in Somalia, Fed. Rep. stood at 61.9%. That is the highest value across all 35 years on record.

The figure is up 9.7% on the previous year and up 201.2% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Somalia, Fed. Rep. peaked at 61.9% in 2024 and was at its lowest, 0.0%, in 1990.

That places Somalia, Fed. Rep. 104th out of 149 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 1.2% 0.0% 5.2% 10
2010s 23.9% 8.3% 40.2% 10
2020s 51.4% 43.3% 61.9% 5

Countries ranked near Somalia, Fed. Rep.

  1. 101 Gabon 63.9% compare
  2. 102 Jordan 63.8% compare
  3. 103 Bulgaria 62.1% compare
  4. 105 Costa Rica 61.6% compare
  5. 106 Albania 61.3% compare
  6. 107 St. Kitts and Nevis 61.1% compare

See the full ranking of 149 places β†’

More reference data data for Somalia, Fed. Rep.

All data for Somalia, Fed. Rep. β†’

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Somalia, Fed. Rep.?
Share of the population living with hiv receiving antiretroviral therapy in Somalia, Fed. Rep. was 61.9% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Somalia, Fed. Rep.?
The highest recorded value was 61.9% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Somalia, Fed. Rep.?
The lowest recorded value was 0.0% in 1990.
How does Somalia, Fed. Rep. rank for share of the population living with hiv receiving antiretroviral therapy?
Somalia, Fed. Rep. ranks 104th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Somalia, Fed. Rep.?
Over the last ten years it is up 201.2%. The long-run trend across the full record is volatile.
Where does this Somalia, Fed. Rep. data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV Β· JSON β€” 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.